10-Q Filing

HUMANA INC CIK: 49071 Q2 2022

Filing Information

Form Type	10-Q
Accession Number	`0000049071-22-000057`
Period End Date	20220630
Filing Date	20220727
Fiscal Year	2022
Fiscal Period	Q2
XBRL Instance	hum-20220630_htm.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 88 Income Statement 76 Cash Flow Statement 85 Stockholders Equity 44 Comprehensive Income 40

Balance Sheet 88 line items

Line Item	Tag	Value	Unit	Period
Receivables, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$72.00M	USD	Point-in-time
Receivables, allowance for doubtful accounts	`AllowanceForDoubtfulAccountsReceivableCurrent`	$83.00M	USD	Point-in-time
Preferred stock, par (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Preferred stock, par (in dollars per share)	`PreferredStockParOrStatedValuePerShare`	$1.00	USD	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized (in shares)	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$5.15B	USD	Point-in-time
Cash and cash equivalents	`CashAndCashEquivalentsAtCarryingValue`	$3.39B	USD	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Preferred stock, shares issued (in shares)	`PreferredStockSharesIssued`	0.00	shares	Point-in-time
Investment securities	`ShortTermInvestments`	$13.04B	USD	Point-in-time
Investment securities	`ShortTermInvestments`	$13.19B	USD	Point-in-time
Common stock, par (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.17	USD	Point-in-time
Receivables, net of allowances of $72 in 2022 and $83 in 2021	`ReceivablesNetCurrent`	$3.37B	USD	Point-in-time
Common stock, par (in dollars per share)	`CommonStockParOrStatedValuePerShare`	$0.17	USD	Point-in-time
Receivables, net of allowances of $72 in 2022 and $83 in 2021	`ReceivablesNetCurrent`	$1.81B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Other current assets	`OtherAssetsCurrent`	$6.49B	USD	Point-in-time
Other current assets	`OtherAssetsCurrent`	$5.39B	USD	Point-in-time
Common stock, shares authorized (in shares)	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	198.67M	shares	Point-in-time
Current assets held-for-sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Common stock, shares issued (in shares)	`CommonStockSharesIssued`	198.65M	shares	Point-in-time
Current assets held-for-sale	`AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$265.00M	USD	Point-in-time
Total current assets	`AssetsCurrent`	$27.22B	USD	Point-in-time
Total current assets	`AssetsCurrent`	$24.89B	USD	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockShares`	69.85M	shares	Point-in-time
Treasury stock, shares (in shares)	`TreasuryStockShares`	72.11M	shares	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.12B	USD	Point-in-time
Property and equipment, net	`PropertyPlantAndEquipmentNet`	$3.07B	USD	Point-in-time
Long-term investment securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$780.00M	USD	Point-in-time
Long-term investment securities	`AvailableForSaleSecuritiesDebtSecuritiesNoncurrent`	$380.00M	USD	Point-in-time
Equity method investments	`EquityMethodInvestments`	$141.00M	USD	Point-in-time
Equity method investments	`EquityMethodInvestments`	$174.00M	USD	Point-in-time
Goodwill	`Goodwill`	$11.09B	USD	Point-in-time
Goodwill	`Goodwill`	$8.91B	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$3.69B	USD	Point-in-time
Other long-term assets	`OtherAssetsNoncurrent`	$4.38B	USD	Point-in-time
Long-term assets held-for-sale	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	$3.33B	USD	Point-in-time
Long-term assets held-for-sale	`DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent`	-	USD	Point-in-time
Total assets	`Assets`	$44.36B	USD	Point-in-time
Total assets	`Assets`	$46.82B	USD	Point-in-time
Benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$8.14B	USD	Point-in-time
Benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$9.65B	USD	Point-in-time
Benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$8.48B	USD	Point-in-time
Benefits payable	`LiabilityForClaimsAndClaimsAdjustmentExpense`	$8.29B	USD	Point-in-time
Trade accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$5.79B	USD	Point-in-time
Trade accounts payable and accrued expenses	`AccountsPayableAndAccruedLiabilitiesCurrent`	$4.51B	USD	Point-in-time
Book overdraft	`BookOverdraftLiability`	$391.00M	USD	Point-in-time
Book overdraft	`BookOverdraftLiability`	$326.00M	USD	Point-in-time
Unearned revenues	`ContractWithCustomerLiabilityCurrent`	$254.00M	USD	Point-in-time
Unearned revenues	`ContractWithCustomerLiabilityCurrent`	$264.00M	USD	Point-in-time
Short-term debt	`DebtCurrent`	$1.95B	USD	Point-in-time
Short-term debt	`DebtCurrent`	$1.54B	USD	Point-in-time
Current liabilities held-for-sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	-	USD	Point-in-time
Current liabilities held-for-sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent`	$206.00M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$17.84B	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$15.33B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$11.29B	USD	Point-in-time
Long-term debt	`LongTermDebtNoncurrent`	$10.54B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$2.38B	USD	Point-in-time
Other long-term liabilities	`OtherLiabilitiesNoncurrent`	$1.91B	USD	Point-in-time
Long-term liabilities held-for-sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	-	USD	Point-in-time
Long-term liabilities held-for-sale	`LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent`	$274.00M	USD	Point-in-time
Total liabilities	`Liabilities`	$28.25B	USD	Point-in-time
Total liabilities	`Liabilities`	$31.31B	USD	Point-in-time
Preferred stock, $1 par; 10,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Preferred stock, $1 par; 10,000,000 shares authorized; none issued	`PreferredStockValue`	-	USD	Point-in-time
Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,666,598 shares issued at June 30, 2022 and 198,648,742 shares at December 31, 2021	`CommonStockValue`	$33.00M	USD	Point-in-time
Common stock, $0.16 2/3 par; 300,000,000 shares authorized; 198,666,598 shares issued at June 30, 2022 and 198,648,742 shares at December 31, 2021	`CommonStockValue`	$33.00M	USD	Point-in-time
Capital in excess of par value	`AdditionalPaidInCapitalCommonStock`	$3.08B	USD	Point-in-time
Capital in excess of par value	`AdditionalPaidInCapitalCommonStock`	$3.15B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$24.51B	USD	Point-in-time
Retained earnings	`RetainedEarningsAccumulatedDeficit`	$23.09B	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$42.00M	USD	Point-in-time
Accumulated other comprehensive (loss) income	`AccumulatedOtherComprehensiveIncomeLossNetOfTax`	$-1.05B	USD	Point-in-time
Treasury stock, at cost, 72,112,900 shares at June 30, 2022 and 69,846,758 shares at December 31, 2021	`TreasuryStockValue`	$11.16B	USD	Point-in-time
Treasury stock, at cost, 72,112,900 shares at June 30, 2022 and 69,846,758 shares at December 31, 2021	`TreasuryStockValue`	$10.16B	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$23.00M	USD	Point-in-time
Noncontrolling interests	`MinorityInterest`	$20.00M	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.73B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.84B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.51B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.10B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.19B	USD	Point-in-time
Total stockholders equity	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.34B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$44.36B	USD	Point-in-time
Total liabilities and stockholders equity	`LiabilitiesAndStockholdersEquity`	$46.82B	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Premiums	`PremiumsEarnedNet`	$22.27B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$40.10B	USD	2 Qtrs
Premiums	`PremiumsEarnedNet`	$19.98B	USD	1 Quarter
Premiums	`PremiumsEarnedNet`	$44.97B	USD	2 Qtrs
Services	`RevenueFromContractWithCustomerIncludingAssessedTax`	$957.00M	USD	2 Qtrs
Services	`RevenueFromContractWithCustomerIncludingAssessedTax`	$491.00M	USD	1 Quarter
Services	`RevenueFromContractWithCustomerIncludingAssessedTax`	$2.61B	USD	2 Qtrs
Services	`RevenueFromContractWithCustomerIncludingAssessedTax`	$1.35B	USD	1 Quarter
Investment income	`NetInvestmentIncome`	$254.00M	USD	2 Qtrs
Investment income	`NetInvestmentIncome`	$47.00M	USD	1 Quarter
Investment income	`NetInvestmentIncome`	$176.00M	USD	1 Quarter
Investment income	`NetInvestmentIncome`	$50.00M	USD	2 Qtrs
Total revenues	`Revenues`	$41.31B	USD	2 Qtrs
Total revenues	`Revenues`	$20.64B	USD	1 Quarter
Total revenues	`Revenues`	$47.63B	USD	2 Qtrs
Total revenues	`Revenues`	$23.66B	USD	1 Quarter
Benefits	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$17.15B	USD	1 Quarter
Benefits	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$34.45B	USD	2 Qtrs
Benefits	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$19.10B	USD	1 Quarter
Benefits	`PolicyholderBenefitsAndClaimsIncurredHealthCare`	$38.72B	USD	2 Qtrs
Operating costs	`SellingGeneralAndAdministrativeExpense`	$4.12B	USD	2 Qtrs
Operating costs	`SellingGeneralAndAdministrativeExpense`	$2.12B	USD	1 Quarter
Operating costs	`SellingGeneralAndAdministrativeExpense`	$3.17B	USD	1 Quarter
Operating costs	`SellingGeneralAndAdministrativeExpense`	$6.06B	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortizationIncomeStatement`	$175.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortizationIncomeStatement`	$144.00M	USD	1 Quarter
Depreciation and amortization	`DepreciationAndAmortizationIncomeStatement`	$286.00M	USD	2 Qtrs
Depreciation and amortization	`DepreciationAndAmortizationIncomeStatement`	$345.00M	USD	2 Qtrs
Total operating expenses	`BenefitsLossesAndExpenses`	$22.45B	USD	1 Quarter
Total operating expenses	`BenefitsLossesAndExpenses`	$19.41B	USD	1 Quarter
Total operating expenses	`BenefitsLossesAndExpenses`	$45.13B	USD	2 Qtrs
Total operating expenses	`BenefitsLossesAndExpenses`	$38.85B	USD	2 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$2.50B	USD	2 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$2.46B	USD	2 Qtrs
Income (loss) from operations	`OperatingIncomeLoss`	$1.24B	USD	1 Quarter
Income (loss) from operations	`OperatingIncomeLoss`	$1.22B	USD	1 Quarter
Interest expense	`InterestExpense`	$101.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$147.00M	USD	2 Qtrs
Interest expense	`InterestExpense`	$79.00M	USD	1 Quarter
Interest expense	`InterestExpense`	$191.00M	USD	2 Qtrs
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$-534.00M	USD	2 Qtrs
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$29.00M	USD	2 Qtrs
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$8.00M	USD	1 Quarter
Other (income) expense, net	`OtherNonoperatingIncomeExpense`	$-419.00M	USD	1 Quarter
Income (loss) before income taxes and equity in net earnings	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.12B	USD	1 Quarter
Income (loss) before income taxes and equity in net earnings	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$2.34B	USD	2 Qtrs
Income (loss) before income taxes and equity in net earnings	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$1.78B	USD	2 Qtrs
Income (loss) before income taxes and equity in net earnings	`IncomeLossFromContinuingOperationsBeforeIncomeTaxesMinorityInterestAndIncomeLossFromEquityMethodInvestments`	$738.00M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$416.00M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$713.00M	USD	2 Qtrs
Provision for income taxes	`IncomeTaxExpenseBenefit`	$427.00M	USD	1 Quarter
Provision for income taxes	`IncomeTaxExpenseBenefit`	$183.00M	USD	1 Quarter
Equity in net earnings (losses)	`IncomeLossFromEquityMethodInvestments`	$33.00M	USD	1 Quarter
Equity in net earnings (losses)	`IncomeLossFromEquityMethodInvestments`	$54.00M	USD	2 Qtrs
Equity in net earnings (losses)	`IncomeLossFromEquityMethodInvestments`	$2.00M	USD	1 Quarter
Equity in net earnings (losses)	`IncomeLossFromEquityMethodInvestments`	$-2.00M	USD	2 Qtrs
Net income	`ProfitLoss`	$1.63B	USD	2 Qtrs
Net income	`ProfitLoss`	$697.00M	USD	1 Quarter
Net income	`ProfitLoss`	$588.00M	USD	1 Quarter
Net income	`ProfitLoss`	$1.42B	USD	2 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	2 Qtrs
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	1 Quarter
Less: Net income attributable to noncontrolling interests	`NetIncomeLossAttributableToNoncontrollingInterest`	$1.00M	USD	2 Qtrs
Net income attributable to Humana	`NetIncomeLoss`	$1.42B	USD	2 Qtrs
Net income attributable to Humana	`NetIncomeLoss`	$588.00M	USD	1 Quarter
Net income attributable to Humana	`NetIncomeLoss`	$696.00M	USD	1 Quarter
Net income attributable to Humana	`NetIncomeLoss`	$1.63B	USD	2 Qtrs
Basic earnings per common share (in dollars per share)	`EarningsPerShareBasic`	$4.57	USD	1 Quarter
Basic earnings per common share (in dollars per share)	`EarningsPerShareBasic`	$5.50	USD	1 Quarter
Basic earnings per common share (in dollars per share)	`EarningsPerShareBasic`	$11.00	USD	2 Qtrs
Basic earnings per common share (in dollars per share)	`EarningsPerShareBasic`	$12.83	USD	2 Qtrs
Diluted earnings per common share (in dollars per share)	`EarningsPerShareDiluted`	$12.77	USD	2 Qtrs
Diluted earnings per common share (in dollars per share)	`EarningsPerShareDiluted`	$5.48	USD	1 Quarter
Diluted earnings per common share (in dollars per share)	`EarningsPerShareDiluted`	$10.94	USD	2 Qtrs
Diluted earnings per common share (in dollars per share)	`EarningsPerShareDiluted`	$4.55	USD	1 Quarter

Cash Flow Statement 85 line items

Line Item	Tag	Value	Unit	Period
Cash and cash equivalents classified as held-for-sale	`DisposalGroupIncludingDiscontinuedOperationCashAndCashEquivalents`	$67.00M	USD	Point-in-time
Net income	`ProfitLoss`	$1.42B	USD	2 Qtrs
Net income	`ProfitLoss`	$588.00M	USD	1 Quarter
Net income	`ProfitLoss`	$697.00M	USD	1 Quarter
Net income	`ProfitLoss`	$1.63B	USD	2 Qtrs
Losses (gains) on investment securities, net	`DebtSecuritiesAvailableForSaleRealizedGainLoss`	$86.00M	USD	2 Qtrs
Losses (gains) on investment securities, net	`DebtSecuritiesAvailableForSaleRealizedGainLoss`	$-137.00M	USD	2 Qtrs
Equity in net losses (earnings)	`IncomeLossFromEquityMethodInvestments`	$-2.00M	USD	2 Qtrs
Equity in net losses (earnings)	`IncomeLossFromEquityMethodInvestments`	$2.00M	USD	1 Quarter
Equity in net losses (earnings)	`IncomeLossFromEquityMethodInvestments`	$33.00M	USD	1 Quarter
Equity in net losses (earnings)	`IncomeLossFromEquityMethodInvestments`	$54.00M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$93.00M	USD	2 Qtrs
Stock-based compensation	`ShareBasedCompensation`	$84.00M	USD	2 Qtrs
Depreciation	`Depreciation`	$308.00M	USD	2 Qtrs
Depreciation	`Depreciation`	$369.00M	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$45.00M	USD	2 Qtrs
Amortization	`AdjustmentForAmortization`	$30.00M	USD	2 Qtrs
Impairment on property and equipment	`TangibleAssetImpairmentCharges`	-	USD	2 Qtrs
Impairment on property and equipment	`TangibleAssetImpairmentCharges`	$140.00M	USD	2 Qtrs
Provision for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	$167.00M	USD	2 Qtrs
Provision for deferred income taxes	`DeferredIncomeTaxExpenseBenefit`	-	USD	2 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$1.28B	USD	2 Qtrs
Receivables	`IncreaseDecreaseInReceivables`	$1.73B	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$655.00M	USD	2 Qtrs
Other assets	`IncreaseDecreaseInOtherOperatingAssets`	$879.00M	USD	2 Qtrs
Benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$1.36B	USD	2 Qtrs
Benefits payable	`IncreaseDecreaseInHealthCareInsuranceLiabilities`	$300.00M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-301.00M	USD	2 Qtrs
Other liabilities	`IncreaseDecreaseInOtherOperatingLiabilities`	$-333.00M	USD	2 Qtrs
Unearned revenues	`IncreaseDecreaseInContractWithCustomerLiability`	$10.00M	USD	2 Qtrs
Unearned revenues	`IncreaseDecreaseInContractWithCustomerLiability`	$5.00M	USD	2 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$-15.00M	USD	2 Qtrs
Other	`OtherOperatingActivitiesCashFlowStatement`	$31.00M	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$1.26B	USD	2 Qtrs
Net cash provided by (used in) operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-477.00M	USD	2 Qtrs
Acquisitions, net of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$325.00M	USD	2 Qtrs
Acquisitions, net of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$167.00M	USD	2 Qtrs
Purchases of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$574.00M	USD	2 Qtrs
Purchases of property and equipment, net	`PaymentsToAcquirePropertyPlantAndEquipment`	$619.00M	USD	2 Qtrs
Purchases of investment securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$3.24B	USD	2 Qtrs
Purchases of investment securities	`PaymentsToAcquireAvailableForSaleSecuritiesDebt`	$5.31B	USD	2 Qtrs
Proceeds from maturities of investment securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$1.63B	USD	2 Qtrs
Proceeds from maturities of investment securities	`ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities`	$947.00M	USD	2 Qtrs
Proceeds from sales of investment securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$2.42B	USD	2 Qtrs
Proceeds from sales of investment securities	`ProceedsFromSaleOfAvailableForSaleSecuritiesDebt`	$1.36B	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-1.67B	USD	2 Qtrs
Net cash used in investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-2.20B	USD	2 Qtrs
Receipts from contract deposits, net	`PaymentsForProceedsFromContractDeposits`	$-1.18B	USD	2 Qtrs
Receipts from contract deposits, net	`PaymentsForProceedsFromContractDeposits`	$-3.08B	USD	2 Qtrs
Proceeds from issuance of senior notes, net	`ProceedsFromIssuanceOfSeniorLongTermDebt`	-	USD	2 Qtrs
Proceeds from issuance of senior notes, net	`ProceedsFromIssuanceOfSeniorLongTermDebt`	$744.00M	USD	2 Qtrs
(Repayments) proceeds from issuance of commercial paper, net	`ProceedsFromRepaymentsOfCommercialPaper`	$-418.00M	USD	2 Qtrs
(Repayments) proceeds from issuance of commercial paper, net	`ProceedsFromRepaymentsOfCommercialPaper`	$508.00M	USD	2 Qtrs
Debt issue costs	`PaymentsOfDebtIssuanceCosts`	$2.00M	USD	2 Qtrs
Debt issue costs	`PaymentsOfDebtIssuanceCosts`	$21.00M	USD	2 Qtrs
Change in book overdraft	`IncreaseDecreaseInBookOverdrafts`	$-84.00M	USD	2 Qtrs
Change in book overdraft	`IncreaseDecreaseInBookOverdrafts`	$65.00M	USD	2 Qtrs
Common stock repurchases	`PaymentsForRepurchaseOfCommonStock`	$33.00M	USD	2 Qtrs
Common stock repurchases	`PaymentsForRepurchaseOfCommonStock`	$1.03B	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$191.00M	USD	2 Qtrs
Dividends paid	`PaymentsOfDividends`	$173.00M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$-11.00M	USD	2 Qtrs
Other	`ProceedsFromPaymentsForOtherFinancingActivities`	$5.00M	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.39B	USD	2 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$2.23B	USD	2 Qtrs
Increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$-1.29B	USD	2 Qtrs
Increase (decrease) in cash and cash equivalents	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect`	$1.83B	USD	2 Qtrs
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.22B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.39B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$4.67B	USD	Point-in-time
Cash and cash equivalents at beginning of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.38B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.38B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$4.67B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$5.22B	USD	Point-in-time
Cash and cash equivalents at end of period	`CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations`	$3.39B	USD	Point-in-time
Interest payments	`InterestPaidNet`	$132.00M	USD	2 Qtrs
Interest payments	`InterestPaidNet`	$171.00M	USD	2 Qtrs
Income tax payments, net	`IncomeTaxesPaidNet`	$373.00M	USD	2 Qtrs
Income tax payments, net	`IncomeTaxesPaidNet`	$386.00M	USD	2 Qtrs
Fair value of assets acquired, net of cash and cash equivalents acquired	`NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1`	$190.00M	USD	2 Qtrs
Fair value of assets acquired, net of cash and cash equivalents acquired	`NoncashOrPartNoncashAcquisitionValueOfAssetsAcquired1`	$602.00M	USD	2 Qtrs
Less: Fair value of liabilities assumed	`NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1`	$277.00M	USD	2 Qtrs
Less: Fair value of liabilities assumed	`NoncashOrPartNoncashAcquisitionValueOfLiabilitiesAssumed1`	$23.00M	USD	2 Qtrs
Cash paid for acquired businesses, net of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$325.00M	USD	2 Qtrs
Cash paid for acquired businesses, net of cash and cash equivalents acquired	`PaymentsToAcquireBusinessesNetOfCashAcquired`	$167.00M	USD	2 Qtrs

Stockholders Equity 44 line items

Line Item	Tag	Value	Unit	Period
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.73B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.84B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.51B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.10B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.19B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.34B	USD	Point-in-time
Net income	`ProfitLoss`	$697.00M	USD	1 Quarter
Net income	`ProfitLoss`	$1.63B	USD	2 Qtrs
Net income	`ProfitLoss`	$1.42B	USD	2 Qtrs
Net income	`ProfitLoss`	$588.00M	USD	1 Quarter
Distribution to noncontrolling interest holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$4.00M	USD	2 Qtrs
Distribution to noncontrolling interest holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	2 Qtrs
Distribution to noncontrolling interest holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	-	USD	1 Quarter
Distribution to noncontrolling interest holders	`MinorityInterestDecreaseFromDistributionsToNoncontrollingInterestHolders`	$4.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$108.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-479.00M	USD	1 Quarter
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-175.00M	USD	2 Qtrs
Other comprehensive income (loss)	`OtherComprehensiveIncomeLossNetOfTax`	$-1.09B	USD	2 Qtrs
Common stock repurchases	`TreasuryStockValueAcquiredCostMethod`	$4.00M	USD	1 Quarter
Common stock repurchases	`TreasuryStockValueAcquiredCostMethod`	$1.03B	USD	2 Qtrs
Common stock repurchases	`TreasuryStockValueAcquiredCostMethod`	$2.00M	USD	1 Quarter
Common stock repurchases	`TreasuryStockValueAcquiredCostMethod`	$33.00M	USD	2 Qtrs
Dividends and dividend equivalents	`DividendsCommonStockCash`	$182.00M	USD	2 Qtrs
Dividends and dividend equivalents	`DividendsCommonStockCash`	$100.00M	USD	1 Quarter
Dividends and dividend equivalents	`DividendsCommonStockCash`	$201.00M	USD	2 Qtrs
Dividends and dividend equivalents	`DividendsCommonStockCash`	$89.00M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$50.00M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$45.00M	USD	1 Quarter
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$84.00M	USD	2 Qtrs
Stock-based compensation	`AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue`	$93.00M	USD	2 Qtrs
Restricted stock unit vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	2 Qtrs
Restricted stock unit vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Restricted stock unit vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	1 Quarter
Restricted stock unit vesting	`StockIssuedDuringPeriodValueRestrictedStockAwardGross`	-	USD	2 Qtrs
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$13.00M	USD	2 Qtrs
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$8.00M	USD	1 Quarter
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$5.00M	USD	2 Qtrs
Stock option exercises	`StockIssuedDuringPeriodValueStockOptionsExercised`	$3.00M	USD	1 Quarter
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.19B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$13.73B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$14.84B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.51B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$16.10B	USD	Point-in-time
Balances	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$15.34B	USD	Point-in-time

Comprehensive Income 40 line items

Line Item	Tag	Value	Unit	Period
Net income attributable to Humana	`NetIncomeLoss`	$696.00M	USD	1 Quarter
Net income attributable to Humana	`NetIncomeLoss`	$1.63B	USD	2 Qtrs
Net income attributable to Humana	`NetIncomeLoss`	$1.42B	USD	2 Qtrs
Net income attributable to Humana	`NetIncomeLoss`	$588.00M	USD	1 Quarter
Change in gross unrealized investment (losses) gains	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-184.00M	USD	2 Qtrs
Change in gross unrealized investment (losses) gains	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-623.00M	USD	1 Quarter
Change in gross unrealized investment (losses) gains	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$-1.39B	USD	2 Qtrs
Change in gross unrealized investment (losses) gains	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodBeforeTax`	$136.00M	USD	1 Quarter
Effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$31.00M	USD	1 Quarter
Effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-320.00M	USD	2 Qtrs
Effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-144.00M	USD	1 Quarter
Effect of income taxes	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodTax`	$-42.00M	USD	2 Qtrs
Total change in unrealized investment (losses) gains, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$105.00M	USD	1 Quarter
Total change in unrealized investment (losses) gains, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-479.00M	USD	1 Quarter
Total change in unrealized investment (losses) gains, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-142.00M	USD	2 Qtrs
Total change in unrealized investment (losses) gains, net of tax	`OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax`	$-1.07B	USD	2 Qtrs
Reclassification adjustment for net realized gains	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$9.00M	USD	1 Quarter
Reclassification adjustment for net realized gains	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	-	USD	1 Quarter
Reclassification adjustment for net realized gains	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$64.00M	USD	2 Qtrs
Reclassification adjustment for net realized gains	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesBeforeTax`	$27.00M	USD	2 Qtrs
Effect of income taxes	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	-	USD	1 Quarter
Effect of income taxes	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$6.00M	USD	2 Qtrs
Effect of income taxes	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$15.00M	USD	2 Qtrs
Effect of income taxes	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesTax`	$2.00M	USD	1 Quarter
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	-	USD	1 Quarter
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$49.00M	USD	2 Qtrs
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$7.00M	USD	1 Quarter
Total reclassification adjustment, net of tax	`OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax`	$21.00M	USD	2 Qtrs
Other comprehensive (loss) income, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-1.09B	USD	2 Qtrs
Other comprehensive (loss) income, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-479.00M	USD	1 Quarter
Other comprehensive (loss) income, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$-191.00M	USD	2 Qtrs
Other comprehensive (loss) income, net of tax	`OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent`	$98.00M	USD	1 Quarter
Comprehensive income attributable to equity method investments	`ComprehensiveIncomeLossNetOfTaxAttributableToEquityMethodInvestments`	$10.00M	USD	1 Quarter
Comprehensive income attributable to equity method investments	`ComprehensiveIncomeLossNetOfTaxAttributableToEquityMethodInvestments`	-	USD	2 Qtrs
Comprehensive income attributable to equity method investments	`ComprehensiveIncomeLossNetOfTaxAttributableToEquityMethodInvestments`	-	USD	1 Quarter
Comprehensive income attributable to equity method investments	`ComprehensiveIncomeLossNetOfTaxAttributableToEquityMethodInvestments`	$16.00M	USD	2 Qtrs
Comprehensive income attributable to Humana	`ComprehensiveIncomeNetOfTax`	$696.00M	USD	1 Quarter
Comprehensive income attributable to Humana	`ComprehensiveIncomeNetOfTax`	$1.24B	USD	2 Qtrs
Comprehensive income attributable to Humana	`ComprehensiveIncomeNetOfTax`	$217.00M	USD	1 Quarter
Comprehensive income attributable to Humana	`ComprehensiveIncomeNetOfTax`	$533.00M	USD	2 Qtrs

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.